BECN1 and gastric adenocarcinoma: More recently, Chen et al (16) reported that decreased expression of Beclin 1 in gastric adenocarcinoma may be important in the acquisition of a metastatic phenotype, suggesting that decreased Beclin 1 expression is an independent biomarker for a poor prognosis in patients with gastric adenocarcinoma.